These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26331164)

  • 1. Retraction notice to “Dual ACE-inhibition and angiotensin IIAT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30].
    Eur J Pharmacol; 2015 Aug; 761():423. PubMed ID: 26331164
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to “Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarction in rat heart” [Eur.J.Pharmacol.January(2015)22–30].
    Eur J Pharmacol; 2015 Aug; 761():423. PubMed ID: 26478933
    [No Abstract]   [Full Text] [Related]  

  • 3. Dual ACE-inhibition and angiotensin II AT1 receptor antagonism with curcumin attenuate maladaptive cardiac repair and improve ventricular systolic function after myocardial infarctionin rat heart.
    Pang XF; Zhang LH; Bai F; Wang NP; Ijaz Shah A; Garner R; Zhao ZQ
    Eur J Pharmacol; 2015 Jan; 746():22-30. PubMed ID: 25445044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Park JS; Park HS; Gwon HC
    BMJ; 2014 Nov; 349():g6650. PubMed ID: 25398372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
    de Resende MM; Mill JG
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the renin-angiotensin system: dual- versus mono-therapy.
    Ravandi A; Teo KK
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
    Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
    Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction notice to "Introduction of antisense oligonucleotides to Heat Shock Protein 47 prevents pulmonary fibrosis in lipopolysaccharide-induced pneumopathy of the rat" [Eur. J. Pharmacol. 564/1-3 (2007) 174-180].
    Hagiwara S; Iwasaka H; Matsumoto S; Noguchi T
    Eur J Pharmacol; 2016 Dec; 792():80. PubMed ID: 27916230
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
    Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
    Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure.
    Banerjee A; Talreja A; Sonnenblick EH; LeJemtel TH
    Mt Sinai J Med; 2003 Sep; 70(4):225-31. PubMed ID: 12968195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACE inhibitors in heart failure: what more do we need to know?
    Demers C; Mody A; Teo KK; McKelvie RS
    Am J Cardiovasc Drugs; 2005; 5(6):351-9. PubMed ID: 16259523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor blockade and ventricular remodelling.
    Anavekar NS; Solomon SD
    J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):43-8. PubMed ID: 16088851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB
    Cardiol Clin; 1995 Aug; 13(3):379-90. PubMed ID: 7585774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
    Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between angiotensin-converting enzyme (insertion/deletion) gene polymorphism and left ventricular remodeling in acute myocardial infarction.
    Ulgen MS; Ozturk O; Alan S; Kayrak M; Turan Y; Tekes S; Toprak N
    Coron Artery Dis; 2007 May; 18(3):153-7. PubMed ID: 17429286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat.
    Ocaranza MP; Godoy I; Jalil JE; Varas M; Collantes P; Pinto M; Roman M; Ramirez C; Copaja M; Diaz-Araya G; Castro P; Lavandero S
    Hypertension; 2006 Oct; 48(4):572-8. PubMed ID: 16908757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction notice to “Memantine enhances the inhibitory effects of naltrexone on ethanol consumption” [Eur.J.Pharmacol.584(2–3) (2008)352–356].
    Eur J Pharmacol; 2015 Aug; 761():424. PubMed ID: 26478934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.